Literature DB >> 34284286

Exosomes synergized with PIONs@E6 enhance their immunity against hepatocellular carcinoma via promoting M1 macrophages polarization.

Hanren Chen1, Shulian Jiang2, Peng Zhang3, Zhongyu Ren3, Jian Wen4.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is easy to relapse after resection for its lack of anti-tumor immunity due to pro-tumorigenesis by promoting M2 type macrophage polarization. Recent studies have shown that exosomes are closely related to the occurrence and development of HCC. Antigenic exosomes from HCC are able to polarize into alternatively activated macrophages M2, but do not stimulate M1 macrophages polarization. Iron oxide nanoparticles (IONs) have been demonstrated to be able to promote M1 macrophages polarization. This research was to explore exosomes as vehicles to synergize with pegylated IONs loaded with chlorin e6 (PIONs@E6) to enhance their immunity against HCC via promoting M1 macrophages polarization.
MATERIALS AND METHODS: PIONs@E6 was synthesized and then characterized by chemico-physical analysis, transmission electron microscope (TEM), respectively. After characterization of PIONs-contained exosomes by TEM, and then the exosomal surface specific molecules CD9 and CD63 were determined by Western Blotting assay. Markers of M1 macrophage polarization in vitro and in vivo were analyzed by enzyme linked immunosorbent assay (ELISA) and flow cytometry, respectively. Intracellular reactive oxygen species (ROS) in macrophages were analyzed using a Spectra Max fluorescence microplate reader. Inhibitory effect of PIONs-contained exosomes on HCC was evaluated by monitoring tumor growth in an in vivo xenograft mice model.
RESULTS: PIONs@E6 showed good water solubility with a core diameter around 10 nm and a hydrate diameter around 37 nm. The expression of exosome specific markers CD9 and CD63 was kept at a high level. PIONs-contained exosomes can dose-dependently promote M1 macrophages polarization in vitro and in vivo. Of note, PIONs-contained exosomes could initiate a significantly higher level of ROS in macrophages and remarkably inhibit the tumor growth in mice bearing HCC xenograft.
CONCLUSION: Exosomes as vehicles could be synergized with PIONs@E6 to enhance their immunity against HCC via promoting M1 macrophages polarization.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exosome; Hepatocellular carcinoma; IONs; Macrophage

Mesh:

Substances:

Year:  2021        PMID: 34284286     DOI: 10.1016/j.intimp.2021.107960

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  Characterization of Lactate Metabolism Score in Breast and Thyroid Cancers to Assist Immunotherapy via Large-Scale Transcriptomic Data Analysis.

Authors:  Cheng Wang; Zheng Qu; Li Chen; Yunhao Pan; Yiqing Tang; Guangfu Hu; Ran Gao; Ruijie Niu; Qiang Liu; Xingyan Gao; Yi Fang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

Review 2.  Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.

Authors:  Bao-Wen Tian; Cheng-Long Han; Zhao-Ru Dong; Si-Yu Tan; Dong-Xu Wang; Tao Li
Journal:  Cancers (Basel)       Date:  2022-08-21       Impact factor: 6.575

3.  A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Yue Li; Huanye Mo; Shengli Wu; Xin Liu; Kangsheng Tu
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.